Tianjin Zhongxin Pharmaceutical

Tianjin Zhongxin Pharmaceutical is one of the...

• CSI 500;
• TOB Iconic 10,000.

Tianjin Zhongxin Pharmaceutical is a company listed under the stock ticker 600329 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Tianjin Zhongxin Pharmaceutical

• Lei Wang, General Manager and Director
• Weiwen Mao, Director
• Min Guo, Director

Create your alert
to follow the executive moves at Tianjin Zhongxin Pharmaceutical.

Tianjin Zhongxin Pharmaceutical has 1,837 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• Molex has announced the acquisition of Vectura Group  (posted on September 23 2024).
• Agilent Technologies has acquired BioVectra (posted on September 23 2024).
• OXB will change its company name to OXB on Sep 18, 2024. (posted on September 18 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Robert Langer - Board Member at Moderna
• Paul Meister - Chairman of the Board at Amneal Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Tianjin Zhongxin Pharmaceutical

Social media about Tianjin Zhongxin Pharmaceutical

• Tianjin Zhongxin Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Zhongxin Pharmaceutical on LinkedIn, Twitter & YouTube

Call Tianjin Zhongxin Pharmaceutical at +86 222...

View the org chart

Register to receive your alert

Report an error